当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:81.72亿  总市值:81.72亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,408,731,310.21,624,749,777.68703,053,747.483,425,737,841.94
  收到的税费返还---437,025.2
  收到其他与经营活动有关的现金206,417,695.22107,610,357.5342,518,547.68103,712,180.22
  经营活动现金流入小计2,615,149,005.421,732,360,135.21745,572,295.163,529,887,047.36
  购买商品、接受劳务支付的现金576,240,178.76398,995,042.23233,909,786.73811,199,696.44
  支付给职工以及为职工支付的现金317,273,900.22208,043,744.99108,584,238.38456,718,845.15
  支付的各项税费231,061,331.98158,283,398.49101,619,363.46390,417,317.1
  支付其他与经营活动有关的现金895,693,453.15613,682,062.06243,945,489.171,300,702,508.42
  经营活动现金流出小计2,020,268,864.111,379,004,247.77688,058,877.742,959,038,367.11
  经营活动产生的现金流量净额594,880,141.31353,355,887.4457,513,417.42570,848,680.25
二、投资活动产生的现金流量:
  取得投资收益收到的现金119,739,821.0849,601,318.7928,536,327.6463,574,902.18
  处置固定资产、无形资产和其他长期资产收回的现金净额1,941,0001,888,5001,384,000486,500
  收到的其他与投资活动有关的现金3,823,510,038.552,481,747,750.271,092,000,0001,840,599,500
  投资活动现金流入小计3,945,190,859.632,533,237,569.061,121,920,327.641,904,660,902.18
  购建固定资产、无形资产和其他长期资产支付的现金82,066,364.7656,315,581.8414,291,462.43101,806,190.5
  投资支付的现金---6,600,000
  支付其他与投资活动有关的现金4,774,160,986.583,140,816,300.471,455,816,300.471,818,000,000
  投资活动现金流出小计4,856,227,351.343,197,131,882.311,470,107,762.91,926,406,190.5
  投资活动产生的现金流量净额-911,036,491.71-663,894,313.25-348,187,435.26-21,745,288.32
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,000,000
  其中:子公司吸收少数股东投资收到的现金---1,000,000
  取得借款收到的现金15,344,80015,344,8006,787,80053,325,000
  收到其他与筹资活动有关的现金---26,865,899.03
  筹资活动现金流入小计15,344,80015,344,8006,787,80081,190,899.03
  偿还债务支付的现金68,672,815.1567,470,15067,000,000133,500,000
  分配股利、利润或偿付利息支付的现金101,953,700.22101,857,965.19160,435.16307,117,606.36
  其中:子公司支付给少数股东的股利、利润---2,560,000
  支付其他与筹资活动有关的现金867,141.34867,141.34792,446.855,206,493.35
  筹资活动现金流出小计171,493,656.71170,195,256.5367,952,882.01445,824,099.71
  筹资活动产生的现金流量净额-156,148,856.71-154,850,456.53-61,165,082.01-364,633,200.68
四、汇率变动对现金及现金等价物的影响-713,875.76-243,672.26-39,683.25360,634.3
五、现金及现金等价物净增加额-473,019,082.87-465,632,554.6-351,878,783.1184,830,825.55
  加:期初现金及现金等价物余额1,120,473,303.891,120,473,303.891,120,473,303.89935,642,478.34
  期末现金及现金等价物余额647,454,221.02654,840,749.29768,594,520.791,120,473,303.89
补充资料:
  净利润-231,288,231.71-514,940,434.63
  资产减值准备-44,149,228.19-56,025,858.73
  固定资产和投资性房地产折旧-86,657,238.64-210,979,129.89
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-86,657,238.64-210,979,129.89
  无形资产摊销-4,675,759.69-9,900,425.68
  长期待摊费用摊销-231,789.41-2,093,281.41
  处置固定资产、无形资产和其他长期资产的损失--419,694.25-139,530.24
  固定资产报废损失-0-630,555.03
  公允价值变动损失--20,859,960.15--10,528,296.23
  财务费用-1,267,083.45-6,402,677.51
  投资损失--34,665,215.33--62,304,296.38
  递延所得税-7,592,436.57-2,012,966.13
  其中:递延所得税资产减少-6,410,210.39-2,413,744.04
    递延所得税负债增加-1,182,226.18--400,777.91
  存货的减少-31,813,609.43--115,040,476.82
  经营性应收项目的减少--28,004,246.65--20,822,679.74
  经营性应付项目的增加--8,252,046.22-4,554,675.07
  其他-24,479,166.96--25,942,361.35
  现金的期末余额-654,840,749.29-1,120,473,303.89
  减:现金的期初余额-1,120,473,303.89-935,642,478.34
  现金及现金等价物的净增加额--465,632,554.6-184,830,825.55
公告日期2025-10-292025-08-282025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑